Profound Medical to Participate in the Stifel 2023 Healthcare Conference
TORONTO, Nov. 08, 2023 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the Stifel 2023 Healthcare Conference on Wednesday, November 15, 2023 at 8:35 a.m. Eastern Time in NYC.
Related news for (PROF)
- Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction
- Profound Medical Annual General and Special Meeting of Shareholders Voting Results
- Profound Medical AUA 2025 Investor Event Agenda
- Save the Date: Profound Medical to Host Investor Event at AUA 2025
- Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results